Study of Daclizumab in Patients With Chronic, Persistent Asthma

Phase 2

Completed

• Conditions: Asthma

• Registration Number: NCT00028288
• Lead Sponsor: Facet Biotech

Brief Summary

The purpose of the study is to evaluate an investigational medication to treat chronic persistent asthma. The research is being conducted at up to 22 clinical research sites in the US and is open to both men and women ages 18 to 70 years old. Participants in the study will have a number of visits to a research site over a 10-month period. All study-related care and medication is provided to qualified participants at no cost: this includes all visits, examinations and laboratory work.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-09
• Study First Submitted: 2001-12-19
• Study First Submitted QC: 2001-12-19
• Study First Posted: 2001-12-20
• Primary Completion: 2003-12
• Study Completion: 2003-12
• Status Verified: 2012-03
• Last Update Submitted: 2012-03-09
• Last Update Posted: 2012-03-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• History of asthma for 6 or more months
• History of chronic persistent asthma requiring daily high dose inhaled corticosteroid for 3 or more months prior to enrollment

Exclusion Criteria

• Patients with 10 or more pack years of smoking history or smoking within 12 months of study enrollment
• No significant disease other than asthma

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (18)

Medical Research Associates; 🇺🇸 Long Beach, California, United States

Southern California Research; 🇺🇸 Mission Viejo, California, United States

Institute of Health Care Assessment, Inc.; 🇺🇸 San Diego, California, United States

Bensch Research Associates; 🇺🇸 Stockton, California, United States

National Jewish Medical and Research Center; 🇺🇸 Denver, Colorado, United States

Clinical Reserch Centers of Colorado; 🇺🇸 Denver, Colorado, United States

Florida Center for Allergy and Asthma Reserch; 🇺🇸 Miami, Florida, United States

Rx Research; 🇺🇸 Woodstock, Georgia, United States

ICSL Clinical Studies; 🇺🇸 Bloomington, Illinois, United States

Asthma and Allergy Center of Chicago, S.C.; 🇺🇸 River Forest, Illinois, United States

Scroll for more (8 remaining)